A Retrospective Study to Evaluate Treat-to-Target and Disease Modification in Adult Participants With Crohn's Disease and Ulcerative Colitis in Real World Setting

This study focuses on Inflammatory Bowel Disease (IBD), which includes Crohn's disease and ulcerative colitis. These are ongoing conditions that cause inflammation in your digestive system and can lead to various symptoms and difficulties. To help people with IBD live better lives, doctors often follow a 'treat-to-target' strategy. This means they set specific goals for treatment, like reducing inflammation to certain levels, to try and achieve the best possible long-term health for the patient.

Researchers want to see how this 'treat-to-target' approach is actually used by doctors in different places and understand if it genuinely helps improve patient outcomes over time. They will be looking at existing medical records from adults who have had Crohn's or ulcerative colitis for at least two years. By studying this information, they hope to get a clearer picture of how effective this treatment strategy is in the real world.

This is called an 'observational' study because the researchers are not giving new treatments or asking patients to do anything differently. Instead, they are simply reviewing medical information that has already been collected as part of routine patient care. This helps them understand patterns and connections in how the disease is managed and how patients respond, without adding any burden to the patients themselves.